MedPath
HSA Approval

GLYNASE TABLET 5 mg

SIN08508P

GLYNASE TABLET 5 mg

GLYNASE TABLET 5 mg

January 5, 1996

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A10BB07

glipizide

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

USV PRIVATE LIMITED

Active Ingredients

GLIPIZIDE

5 mg

Glipizide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.